GLASS分级与BASIL-1试验血运重建后临床结局的关系
基于BASIL-1试验377例慢性肢体威胁性缺血患者,评估GLASS与血运重建结局的关系。GLASS与EVT组的技术失败、无截肢生存、保肢及免于主要肢体不良事件相关,但与BS组结局无关。在GLASS II和III级中,BS的FF-MALE优于EVT。
要点
- GLASS与EVT后的技术失败、无截肢生存、保肢和FF-MALE显著相关。
- GLASS与旁路手术后的上述结局无显著关系。
- GLASS II和III级患者中,旁路手术的FF-MALE优于腔内治疗。
核心结论
- 在BASIL-1队列中,GLASS与EVT后结局相关,但与BS后结局无关。
研究设计与样本
- 对BASIL-1试验(1999-2004年随机)中377例接受EVT(n=213)或BS(n=164)的患者进行回顾性分析。
主要发现
- BS组中GLASS与上述结局均无显著关系。
临床怎么用
- GLASS可能有助于CLTI血运重建的共享决策,尤其在EVT与BS选择时。
- GLASS可用于未来试验的患者分层。
局限性
- 需在当代CLTI队列中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Global Vascular Guideline on chronic limb threatening ischaemia (CLTI) has introduced the Global Limb Anatomic Staging System (GLASS) as a new angiographic scoring system. However, the relationship between GLASS and outcomes following revascularisation has not previously been studied. METHODS: Using pre-intervention angiograms the relationship between GLASS and immediate technical failure (ITF), amputation free survival (AFS), limb salvage (LS), overall survival (OS), and freedom from major adverse limb events (FF-MALE) was examined in 377 patients undergoing endovascular therapy (EVT, n = 213) or bypass surgery (BS, n = 164) in the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 trial (randomised 1999-2004). RESULTS: There was no significant difference in GLASS between cohorts. There was a significant relationship between ITF and GLASS in EVT (I 14%, II 15%, III 28%, p = .049). GLASS was significantly related to AFS (hazard ratio [HR], 1.37; 95% CI 1.01-1.85; p = .042), LS (HR 1.96; 95 % CI 1.12-3.43; p = .018), and FF-MALE (HR 1.49; 95% CI 1.04-1.87; p = .028) in the EVT cohort. In BS patients, there was no relationship between GLASS and these outcomes. FF-MALE was significantly worse after EVT than BS in GLASS II (p = .038) and III (p = .001). Among the subgroup of patients with femoropopliteal (FP) disease (BS, n = 109 or EVT, n = 159), FF-MALE was significantly higher after BS than EVT (p < .001). The superiority of BS over EVT with increasing GLASS FP grade was greater in the analysis of patients using vein grafts. CONCLUSION: In the BASIL-1 cohort, GLASS is associated with outcomes following EVT but not BS. Although further validation in contemporary CLTI cohorts is required, GLASS seems likely be useful in shared decision making and for stratifying patients in future trials.
引用
- Kodama A, Meecham L, Popplewell M, et al. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial. Eur J Vasc Endovasc Surg. 2020. PMID: 32778491. doi:10.1016/j.ejvs.2020.06.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。